Cargando…

Pacman flap for oncologic reconstruction of soft-tissue defects after tumor resection: A retrospective case series

INTRODUCTION: The Pacman flap is a novel modality for repairing round soft-tissue defects after tumor resection. This modality provides a robust blood supply without microsurgical tissue rearrangement. This article reviews the authors’ experience with Pacman flap for reconstruction of round soft-tis...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guangxue, Mu, Lan, Bi, Ye, Yang, Kai, Liu, Yan, Peng, Zhe, Zhu, Yi, Zang, Huiran, Cao, Saisai, Zhang, Peiyang, Qian, Youlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023656/
https://www.ncbi.nlm.nih.gov/pubmed/29924008
http://dx.doi.org/10.1097/MD.0000000000011114
Descripción
Sumario:INTRODUCTION: The Pacman flap is a novel modality for repairing round soft-tissue defects after tumor resection. This modality provides a robust blood supply without microsurgical tissue rearrangement. This article reviews the authors’ experience with Pacman flap for reconstruction of round soft-tissue defects. The safety and effectiveness of the Pacman flap are investigated. METHODS: Here, we describe a method for oncologic reconstruction of round soft-tissue defects with a Pacman flap after tumor resection. Fourteen consecutive patients (6 males and 8 females, median age of 60 years, range, 18–87 years) who received Pacman flaps for oncologic reconstruction during the period from April 2015 to April 2017 were included in the present study. RESULTS: In total, 15 Pacman flaps (including 1 bilateral Pacman flap) were created to provide coverage after resection of a tumor from the face (n = 11), chest (n = 1), or extremities (n = 2). One patient had twice previously undergone tumor resection. Median defect size was 25.5 × 25 mm (range, 9 × 9–100 × 90 mm). Median flap size was 35 × 27 mm (range, 12 × 10–120 × 110 mm). Median duration of follow-up was 10 months (range, 6–22 months). No local or distal tumor was observed during the follow-up period. All flaps survived without partial or complete necrosis, infection, or other complications. All patients were satisfied with their aesthetic outcomes. A hematoma formed in 1 patient and was successfully treated with debridement. CONCLUSIONS: The Pacman flap enables the surgeon to achieve tension-free round defect closure after tumor resection, with good functional and aesthetic outcomes. This modality is a reliable and effective reconstructive surgical technique for oncologic reconstruction of round soft-tissue defects.